fda glp-1 compounded warning september 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA's compounded GLP-1 limits will
Description
Read about how we use cookies
Lancet 386, 8596

Moreover, we offer flexibility in designing weight loss drug coverage to meet the specific needs of our plan sponsors

[DOI] [PubMed] [Google Scholar] 201.Ghusn W., Hurtado M.D